glp-1 lipedema update (after 40 lb weight loss on GLP-1) : r/lipedema ✨ Lipedema & GLP-1 Meds:

For example, no relationship was found between age and GSH levels in the anterior cingulate cortex (ACC) in a pediatric sample (age 5.613.9 years) 10

Careful ca [...]

Evaluating rezatapopt*, a first-in-class p53 reactivator, as a treatment for TP53 Y220Cmutant locally advanced and metastatic solid tumours The experts discuss: TP53 Y220C mutation and rationale for targeted therapy Study overview and practice implications, spotlighting ovarian cancer Testing strategies for early and accurate patient identification Video in this post *Rezatapopt is an investigational agent which is not approved by a regulatory agency This programme has been sponsored by PMV Pharma #MedicalEducation #Oncology Update from AACRNCIEORTC 2025: PYNNACLE Phase 2 evaluating rezatapopt in TP53 Y220Cmutant solid tumours To view or add a comment, sign in 26,264 followers

It also has gshR and gpo homologs suggesting the ability to use the imported glutathione for redox reactions